Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.16 USD
127.03 M USD
413.98 M USD
421.95 M
About Consun Pharmaceutical Group Ltd.
Sector
Industry
CEO
Meng An
Website
Headquarters
Guangzhou
Founded
1997
IPO date
Dec 19, 2013
Identifiers
3
ISIN KYG2524A1031
Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through the Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium. The Yulin Pharmaceutical segment retails traditional Chinese medicines. The company was founded by Qian Li in 1997 and is headquartered in Guangzhou, China.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
TLTE
FlexShares Morningstar Emerging Markets Factor Tilt Index FundWeight
0.12%
Market value
379.98 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of CPHGF is 1.65 USD — it has decreased by −17.50% in the past 24 hours. Watch CONSUN PHARMACEUTICAL GROUP LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CONSUN PHARMACEUTICAL GROUP LTD. stocks are traded under the ticker CPHGF.
CPHGF reached its all-time high on Jan 2, 2026 with the price of 2.00 USD, and its all-time low was 1.04 USD and was reached on Dec 10, 2024. View more price dynamics on CPHGF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CPHGF stock is 21.21% volatile and has beta coefficient of 0.32. Track CONSUN PHARMACEUTICAL GROUP LTD. stock price on the chart and check out the list of the most volatile stocks — is CONSUN PHARMACEUTICAL GROUP LTD. there?
Today CONSUN PHARMACEUTICAL GROUP LTD. has the market capitalization of 1.93 B, it has decreased by −0.85% over the last week.
Yes, you can track CONSUN PHARMACEUTICAL GROUP LTD. financials in yearly and quarterly reports right on TradingView.
CONSUN PHARMACEUTICAL GROUP LTD. is going to release the next earnings report on Apr 1, 2026. Keep track of upcoming events with our Earnings Calendar.
CPHGF net income for the last half-year is 68.16 M USD, while the previous report showed 71.29 M USD of net income which accounts for −4.38% change. Track more CONSUN PHARMACEUTICAL GROUP LTD. financial stats to get the full picture.
CONSUN PHARMACEUTICAL GROUP LTD. dividend yield was 7.36% in 2024, and payout ratio reached 49.91%. The year before the numbers were 9.43% and 41.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 3.16 K employees. See our rating of the largest employees — is CONSUN PHARMACEUTICAL GROUP LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONSUN PHARMACEUTICAL GROUP LTD. EBITDA is 153.88 M USD, and current EBITDA margin is 34.41%. See more stats in CONSUN PHARMACEUTICAL GROUP LTD. financial statements.
Like other stocks, CPHGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONSUN PHARMACEUTICAL GROUP LTD. stock right from TradingView charts — choose your broker and connect to your account.